Monitoring HIV-1 in the Asia-Pacific – Lessons for national surveillance of Ebola.
Summary: Human immunodeficiency virus (HIV) type 1 (HIV-1) group M accounts for most HIV infections globally. However, despite more than 30 years of unprecedented technological, methodological and therapeutic advances, HIV-1 infection cannot be prevented by vaccination or eradicated from infected patients. In this presentation, HIV-1 natural history in the human host are summarised and viral replication processes which contribute to HIV-1 genotype diversity, within the patient and in the wider population, are reviewed. Ebola, like HIV-1, is an RNA virus. Therefore, established methods for surveillance and monitoring of HIV-1 can be readily adapted for evaluating Ebola.
Bio: Dr Rebecca Oyomopito is a classically trained mathematical statistician with a PhD in Epidemiology/Biostatistics and publications on HIV-1 reported in high-impact international journals. Rebecca has experience accumulated from projects in the United States (Harvard School of Public Health), France (Organisation for Economic Co-operation and Development), Australia and the Asia-Pacific.
She currently runs a consultancy based in Pyrmont.
The doors open at 3pm, refreshments available.
The presentation starts at 3.30. Question time follows at 4pm.